Politics

Politics By Lev Facher

AAMC, the medical school trade association, gave $500,000 to dark-money group in 2018

Exclusive By Nicholas Florko

FDA’s reopening plan will keep biologics labs shuttered far longer than other government labs

Special Report By Lev Facher

Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus

Politics By Nicholas Florko

Trump orders government to buy certain drugs solely from U.S. factories, setting up major shakeup for industry

Politics By Amy Sokolow

Scientists are testing pricey rare-disease drugs as Covid-19 treatments. What if one works?

Politics By Nicholas Florko

The FDA is finalizing its long-awaited rules for CBD

Politics By Nicholas Florko and Lev Facher

The drug industry’s new tactic in Washington: calling Trump’s bluff 

Politics By Lev Facher

Liberal group warns that the U.S. is unprepared to distribute a Covid-19 vaccine

Politics By Lev Facher

Covid-19 relief package likely to include billions more for vaccines, testing

Politics By Nicholas Florko and Lev Facher

Trump administration unveils executive orders to curb drug prices — but they come with caveats

Politics By Nicholas Florko

The FDA got a lot more flexible during Covid — and pharma’s already pushing to make it permanent

Exclusive By Nicholas Florko

In unusual arrangement, deputy HHS secretary’s wife has been lobbying the agency on behalf of health care companies

Politics By Damian Garde

Pharma promises lawmakers, again and again, industry won’t cut corners with Covid-19 vaccines

Politics By Lev Facher

Many drug companies working on Covid-19 vaccines and treatments are lobbying harder than usual

Politics By Damian Garde

Two lawmakers own large sums of stock in vaccine makers set to testify before their committee

Health By Damian Garde and Helen Branswell

6 burning questions Congress could push Covid-19 vaccine makers to answer today

Politics By Lev Facher

NIH Director Francis Collins defends Fauci amid White House criticism 

Politics By Nicholas Florko and Eric Boodman

How HHS’s new hospital data reporting system will actually affect the U.S. Covid-19 response

Politics By Amy Sokolow

Opioid overdoses have skyrocketed amid the coronavirus, but states are nevertheless slashing addiction treatment program budgets 

Politics By Matthew Herper

U.S. must spend $75 billion to fix flawed Covid-19 testing, report says

Politics By Lev Facher

What’s next for Anthony Fauci, if the White House continues to sour on him?

Special Report By Nicholas Florko

The CDC has always been an apolitical island. That’s left it defenseless against Trump

Politics By Shraddha Chakradhar

‘I feel like I am not welcome’: Medical, doctoral students from abroad grapple with uncertainty from new ICE rules

Health By Matthew Herper

A flawed Covid-19 study gets the White House’s attention — and the FDA may pay the price

Politics By Nicholas Florko

Drug makers sue to block Minnesota law making it cheaper to get insulin in emergencies

Politics By Lev Facher

Trouble in paradise: The Senate’s bipartisan accord on drug prices is broken, says Grassley 

Health By Andrew Joseph

As Covid-19 cases surge, Pence touts progress made from earlier peaks

Politics By Nicholas Florko

Ousted federal vaccine expert alleges health secretary has continued to retaliate

Politics By Lev Facher

Top U.S. health officials say they were never told to slow down Covid-19 testing, contradicting Trump